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Abstract
Accurate characterization of populations, as captured by International Classification
of Diseases (ICD) codes, is key to healthcare decision-making. Despite being
assigned by professionally trained and certified coders, these codes are frequently
imprecise. We present a methodology that uses deep learning to model coder
decision-making by assigning ICD codes to inpatient encounters. This creates
clinical phenotypes derived from discrete data elements in the medical record. Our
approach assigns codes based on demographics, lab results, and medications, as
well as codes from previous encounters. Using diabetes as a test case, the model
was able to predict existing codes with high accuracy. We then employed a panel
of practicing physicians who, in a blinded manner, established an independent
ground truth which we used to assess the accuracy of our model. In cases where
the model strongly disagreed with the existing codes, the physician review agreed
overwhelmingly with the model. Furthermore, the model-predicted probability of
diabetes tracked closely to the physician-established likelihood of diabetes. Our
data suggests that 9.07% of cases had missing or incorrect ICD codes for diabetes.
1 Introduction
Accurate identification, documentation, and coding of disease is important to health care, relating
directly to patient care, revenue, and performance evaluation. ICD (International Classification of
Diseases) codes are used to classify mortality, define cohorts, evaluate health care policy, and drive
health care finance. Despite their importance, there is considerable inaccuracy and variability in these
assigned codes [6, 11]. Recently, there has been high interest in the use of deep learning methods to
overcome obstacles to working with Electronic Health Records (EHR) data; specifically, focused on
prediction of patient diagnosis, readmission and mortality [2, 3, 5, 7, 8, 10, 13]. More applications of
deep learning in EHR are discussed in survey works [9, 14] thoroughly.
In this paper, we tackle the problem of disease phenotyping – generating EHR based diagnosis codes
or flagging existing codes which may need revision. For this purpose, first we train a deep learning
model to mimic coder behavior for assigning diagnosis codes based on discrete data available for
each patient’s visit. After optimizing this model, we study cases where the model prediction was
different from the coders’ annotation. We then analyze these discordant cases by sampling from
different intervals of the model’s output probability, followed by reviewing these cases with a group
of experts. In this work, we focus on diabetes for analyzing discordant cases in detail, but the model
and training methodology do not contain any disease-specific choices.
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Table 1: Aggregated statistics for each specific test in each encounter
Statistics Description
Count Number of times test was ordered
Min Minimum value between all values
Max Maximum value between all values
Median Median of all values
Values’ concepts Number of times values fall in high, normal or low
ranges defined by the facility
Delta Last value minus first value
2 Data
Data for this study were extracted from the Cerner HealthFacts database, a large multi-institutional
de-identified database derived from EHRs and administrative systems. There are 599 facilities in this
database, consisting of both inpatient and outpatient encounters. We selected cohorts of inpatient
encounters: (1) from large volume acute-care facilities, (2) from facilities which report laboratory
tests and diagnosis codes, and (3) of patients 50 years and older (who are majority of diabetes cases).
The main dataset for this manuscript is from facility 143, which was chosen randomly from the top
10 volume facilities in this database for the time period 8/24/2006 to 12/31/2013.
After mapping all extracted data to the OHDSI Common Data Model (version 5.3), we combined all
available data of each encounter, including demographic information, laboratory results, medications
and observations for creating our feature matrix. All categorical features were converted to vector
format using a 1-hot encoding scheme. Our target phenotype was a combination of all diabetes
diagnosis codes (defined by CCS codes 49 & 50), meaning if any ICD code related to diabetes is
reported, the patient is diabetic and is a positive case in our feature matrix. Since the number and
frequency of each laboratory result varies between different encounters, we aggregated all of the
values from each test in statistics elaborated in Table 1.
3 Methodology
Given that many patient tests are unresulted, we reduce the sparsity of our data by removing irrelevant
features. Since many tests are unrelated to our target disease, we only keep features that are common
in at least 5% of positive cases in the training set. By doing so, we reduced the number of features
from 13,139 to 966. Diagnosis codes are assigned based on a specific set of guidelines and rules.
By investigating thousands of training data points, we expect a deep learning model to discover
such patterns. Deep Learning models are ideal for these tasks, as they do not require a separate
feature selection step and they perform well with a relatively large feature space. In this work, we
decided to use a multilayer perceptron network. More than 2/3 of patients had no previous encounter
information; therefore, a time series model like a recurrent neural network was not suitable. We chose
to select a modeling framework that ran well on the majority of patients where no prior information
was available, reflecting a more real-world application. Furthermore, laboratory results do not provide
clinical value after a long time period, and the salient information about patient history is better
captured in disease codes from previous encounters. As a result, we aggregated previous encounter
information into one binary vector of diagnosis codes, representing whether a patient had that disease
code in any previous encounter. We applied this strategy for all individual diagnosis codes, as well as
for the aggregated code for the target disease - diabetes.
3.1 Neural Network Architecture
We implemented a multilayer perceptron Deep Neural Network (DNN) for this study. The input layer
has 966 features and the output is a single neuron consisting of sigmoid activation function, assigning
probability to each input vector. We performed extensive hyperparameter tuning over a variety of
activation functions (tanh, ReLU and SeLU), optimizers (Adam, SGD), loss functions (mean squared
error, mean absolute error, binary cross-entropy and categorical hinge), and numbers of hidden layers
(ranging 2 to 15). A network with 10 hidden layers consisting of tanh activation function using Adam
optimizer and mean squared error as loss function achieved the best result. To avoid overfitting, L1
regularization and dropout were employed.
To train the deep learning model, we used the Python programming language (2.7), Keras framework
with underlying Tensorflow, and scikit learn library. The training was performed on a single computer
with a NVIDIA Tesla V100 (16GB RAM) [1, 4, 12].
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Table 2: Comparison with machine learning models
Algorithm Precision Recall F1-Score AUCROC AP
Deep Neural Network 0.79 0.82 0.80 0.92 0.81
Logistic Regression 0.75 0.79 0.77 0.90 0.78
Random Forest 0.80 0.66 0.72 0.90 0.77
LinearSVC 0.74 0.75 0.75 0.82 0.63
(a) Precision recall curve (b) Receiver operating characteristic curve
Figure 1: DNN model performance analysis on the test set
4 Results
4.1 Deep learning method performance
20% of data was untouched for test set and the rest was divided into training and validation sets.
All results are based on test set. We compared the trained DNN to three popular machine learning
methods. As shown in Table 2, the deep learning method surpassed the other machine learning
algorithms in all aggregated metrics: F1-Score, AUC-ROC, and Average Precision. Since our dataset
is imbalanced (30% prevalence), we prioritized the F1-score which balances precision and recall.
In Figure 1, we demonstrate how the model performs across different levels of model confidence.
For comparison, dashed lines show how a random classifier would perform. Notably, our model
maintained a precision above 80% until recall reached nearly 80%.
4.2 Analyzing model-coder discordant cases
We expected diabetes prediction to be relatively straightforward, given that many lab values and
medications are specific to diabetes. However, when validated against the coders’ diagnoses, the
model performance was lower than anticipated. Since inconsistency in disease codes was a motivation
for this study, we asked a group of three physicians to review cases in which the model and coders
disagreed. In addition to determining whether each case should or should not be coded for diabetes,
the physicians also noted their own confidence (high or low) in this assessment. This review was
conducted in double-blind fashion, as both the physicians as well as the scientist managing the review
process were unaware of the model and coder labels. As the output of the last layer in deep learning is
a sigmoid function, it is analogous to the model’s assessed probability of being diabetic for each input
vector (p). Discordant cases were grouped based on their probability (p) into one of three bins: High
confidence (p < 0.15 or 0.85 < p) medium confidence ( 0.15 <= p < 0.3 or 0.70 < p <= 0.85)
and low confidence (0.3 <= p <= 0.7). For each confidence interval, we sampled 40 cases (20
each from cases in which diabetes was coded but p < 0.5, or for which diabetes was not coded
but p > 0.5) for review. Expert review, shown in Figure 2a, suggested that the model-generated
probability (p) of diabetes was similar to the actual prevalence of diabetes in each group of cases,
meaning that the coders were wrong at a frequency predicted by the model’s confidence. The coders
were especially incorrect in cases when the model disagreed with high confidence (35/40). Notably,
in 16 out of 20 cases where coders had documented the presence of diabetes, physicians agreed with
the model there was no evidence of disease. Furthermore, among cases that the model flagged with
low confidence, there was also a decrease in the physicians’ confidence.
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Figure 2: a. Summary of expert review in cases where the coders and model disagreed. Dark blue
color reflects cases in which the experts agreed with the model prediction, and vertical error bars
show the 95% confidence interval for the expert-provided rate of diabetes in each set of cases. Grey
hashed areas demonstrate cases where the experts stated low-confidence in their assessments. b.
F1-score across 11 different facilities for a model trained with data from all 11 facilities.
4.3 Multi-Facility expanding
In order to improve the generalizability of our procedure to other facilities, we repeated training the
DNN with combined data from 11 facilities. Ideally, the model should learn cross-facility differences
automatically. The multi-facility data consisted of balanced sampling from 11 facilities shuffled
randomly without any facility ID during training. Aside from this new training data, the other training
procedures were the same as described above. The performance of this model on independent test
data from each of these 11 facilities is shown in Figure 2b. The F1-score for facility 143 when trained
data included 10 other facilities is 0.79 which is very close to what we achieved when we trained and
tested on facility 143 alone (0.80). This suggests that our deep learning strategy has the capability to
account for facility-specific batch effects. Furthermore, for facilities other than 143, results were still
reasonably good, especially when considering the rate at which coder-generated training labels were
shown to be inaccurate in the data from facility 143. This experiment shows this methodology to be
scalable and generalizable among multiple facilities to create one single model for coding diabetes.
4.4 Effect on population prevalence
The expert re-analysis of discordant cases gave us the capability to make a conservative estimate
of global miscoding rates for diabetes (as even concordant cases could be incorrect). Our test set
consisted of 16,797 encounters, 2,082 of which the model disagreed with the coders. From these
2,082 disagreements, the model had high confidence in 748 cases, medium confidence in 787 cases,
and low confidence in 547 cases. Based on our experts experiment and projecting rates onto all of
the discordant tests suggests that about 1,523 cases are incorrectly coded, i.e. 73% of the discordant
cases, and 9.07% of the total population. From these 9.07%, there are 5.68% missing diabetes codes,
and 3.39% where a diabetes diagnosis code is wrongly assigned to the patient and should be removed.
5 Conclusion
A trained deep learning model was successful at reproducing coder-documented presence or absence
of diabetes. Our model is notable, in that it was built with minimal design choices, did not require
medical experts to define feature and is expected to generalize to other diseases. As we built our
model on data mapped to a widely utilized clinical OHDSI CDM (Common Data Model) issues of
data interoperability across institutions are minimized.
The manual review of results confirmed that the model’s performance was concordant with that of
the medical experts. Data suggests that up to 9.07% of encounters are incorrectly coded for diabetes.
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Improved accuracy of diabetic patients, should assist health care systems improve patient registries
and may help them identify patients requiring intensive follow-up care.
The model performed well when challenged with data from multiple institutions, suggesting that with
a sufficiently large training set, we might be able to deploy the model to institutions not included in
the training set.
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